Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Real world study from the CHAMP-HF registry comparing Entresto (sacubitril/valsartan) patients to patients not taking Entresto

Trial Profile

Real world study from the CHAMP-HF registry comparing Entresto (sacubitril/valsartan) patients to patients not taking Entresto

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2018

At a glance

  • Drugs Sacubitril/valsartan (Primary)
  • Indications Chronic heart failure
  • Focus Therapeutic Use
  • Acronyms CHAMP-HF
  • Most Recent Events

    • 04 Jun 2018 New trial record
    • 28 May 2018 Interim data cut results (n=1095) presented in a Novartis media release.
    • 28 May 2018 According to a Novartis media release, the interim data cut (n=1095) were presented as a part of a late-breaking session at the European Society of Cardiology Heart Failure (ESC-HF) Congress 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top